Used in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly those targeting central nervous system disorders. Its structure supports the development of novel agents with potential antidepressant or cognitive-enhancing effects. The presence of trifluoromethoxy and benzyl groups enhances metabolic stability and receptor binding affinity, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in structure-activity relationship (SAR) studies to explore pyrrolidine-based inhibitors or modulators of specific neuronal receptors.